Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 43Neoplasm Metastasis 5Neoplasms 4Ovarian Neoplasms 3Hereditary Sensory and Autonomic Neuropathies 3Carcinoma, Non-Small-Cell Lung 3Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Cancer Metastatic 2Advanced Breast Cancer 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1Hyperglycemia 1HER2-positive Metastatic Breast Cancer 1HER2-positive Breast Cancer 1Female Breast Carcinoma 1Exanthema 1Carcinosarcoma 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Anatomic Stage IV Breast Cancer AJCC v8 1Adenocarcinoma Of Esophagus 1

Interventions

benralizumab 1Sirolimus 1Gels 1Fulvestrant 1Fibroblast Growth Factor 7 1Dapsone 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Exanthema × Fulvestrant × Clear all
NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
1 enrolled 5 charts
Breast

Breast Neoplasms, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡